Pearls & Oy-sters: Homozygous Complement Factor I Deficiency Presenting as Fulminant Relapsing Complement-Mediated
Elle Levit1, Janice Leon2, Matthew R Lincoln2
1From the Yale University School of Medicine (E.L.), New Haven, CT; Miami VA Healthcare System (J.L.), Veterans Health Administration, Miami, FL; Division of Neurology, Department of Medicine (M.R.L.), University of Toronto, ON; Keenan Research Centre for Biomedical Science (M.R.L.), Toronto, ON, Canada. elle.levit@uvmhealth.org.
Abstract:
A 36-year-old man presented multiple times with fever, headache, alteration of mental status, and focal neurologic deficits. MRI revealed extensive white matter lesions that were partially reversed between episodes. Workup revealed persistently low complement factor C3, low factor B, and absent alternative complement pathway activity. Biopsy revealed neutrophilic vasculitis. Genetic testing revealed a homozygous variant in complement factor I (CFI), which was thought to be pathogenic. CFI regulates complement-mediated inflammation, and deficiency in this factor leads to unchecked alternative pathway activity and decrease in C3 and factor B through consumption. The patient has remained stable since starting IL-1β inhibition. Complement factor I is a rare disorder that should be considered in patients with atypical relapsing neurologic disease associated with neutrophilic pleocytosis.
Insights
A rare genetic disorder affecting complement factor I (CFI) caused relapsing neurological symptoms. Treatment with IL-1β inhibition stabilized the patient, highlighting a potential therapeutic target.
Area of Science:
- Immunology
- Neurology
- Genetics
Background:
- The complement system, particularly the alternative pathway, plays a crucial role in innate immunity.
- Complement factor I (CFI) is essential for regulating complement activation.
- Deficiency in CFI can lead to uncontrolled complement activity and systemic inflammation.
Observation:
- A 36-year-old male presented with recurrent neurological episodes including fever, headache, altered mental status, and focal deficits.
- Neuroimaging showed reversible white matter lesions, and laboratory tests revealed low C3, low factor B, and absent alternative pathway activity.
- A biopsy confirmed neutrophilic vasculitis.
Findings:
- Genetic analysis identified a homozygous pathogenic variant in the complement factor I (CFI) gene.
- This deficiency resulted in overactive alternative complement pathway, leading to consumption of C3 and factor B.
- The patient's condition stabilized upon initiation of IL-1β inhibition therapy.
Implications:
- Complement factor I deficiency is a rare but significant cause of relapsing neurological disease.
- This case underscores the importance of considering complement disorders in patients with unexplained neurological and inflammatory symptoms.
- Targeting IL-1β may represent a viable therapeutic strategy for complement-mediated neurological conditions.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
Complement System
Endocarditis II: Clinical Features of Infective Endocarditis
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Nephrotic Syndrome I : Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
